Prostate Cancer Foundation

donate ribbon

Donate Now    FAQs   Contact Us   Español   twitter   facebook

Navigation

Prostate Cancer Research

Funded Research

YOUNG INVESTIGATOR AWARDS—CLASS OF 2014

The Prostate Cancer Foundation selected 27 recipients for the class of 2014 Young Investigator Awards, a nearly $6.1 Million investment toward accelerating research that will improve the lives of prostate cancer patients.

View the recipients here


YOUNG INVESTIGATOR AWARDS—CLASS OF 2013

The Prostate Cancer Foundation announced the funding of 27 new Young Investigator Awards, a nearly $5.8 Million investment in transformational research focused on prostate cancer treatments to improve patient outcomes.

View the recipients here


YOUNG INVESTIGATOR AWARDS—CLASS OF 2012

The Prostate Cancer Foundation announced the funding of 19 new Young Investigator Awards, a nearly $3.4 Million investment in transformational research focused on prostate cancer treatments to improve patient outcomes.

View the recipients here


YOUNG INVESTIGATOR AWARDS—CLASS OF 2011

PCF selected 24 recipients from leading cancer centers in the U.S., Greece and Canada  for the 2011 class of Young Investigators, an investment totaling $5.32 million in the global cancer research community.

View the recipients here


YOUNG INVESTIGATOR AWARDS—CLASS OF 2010

PCF selected 27 recipients from 18 leading cancer centers in the U.S. and Canada for this round of Young Investigator Awards.

View the recipients here


YOUNG INVESTIGATOR AWARDS—CLASS OF 2008

PCF selected 23 recipients for this first round of Young Investigator Awards.

View the recipients here


CHALLENGE AWARDS—CLASS OF 2015

PCF started off 2015 with a $3 Million investment in “Global Treatment Science” (GTS) projects, selecting 3 2015 Challenge Awards from highly qualified research teams around the world that have the highest potential of transformative impact on men being treated for lethal prostate cancer.

View the recipients here 


CHALLENGE AWARDS—CLASS OF 2014

PCF selected 20 2014 Challenge Awards from expert research teams across the globe under a new funding strategy termed “Global Treatment Sciences” (GTS). These “treatment science” awards focus on projects with highly transformative clinical translational potential surrounding major unmet needs related to curability, longevity, and burden in men with metastatic castrate-resistant prostate cancer. Following an extensive peer review process consisting of an external advisory board, PCF selected the top research proposals for funding. The 2014 Challenge Awards include 6 PCF Challenge Awards, 7 Movember-PCF Challenge Awards, 2 The Safeway Foundation-PCF Challenge Awards, 2 Janssen Special Challenge Awards, an All-Star Killer T-cell Special Challenge Award, and a Carl Icahn - PCF Challenge Award. The Challenge Award Class of 2014 represents a $21 Million investment in lethal prostate cancer research.

View the recipients here 


CHALLENGE AWARDS—CLASS OF 2013

PCF selected 8 2013 Challenge Awards from two rounds of RFAs totaling 80 proposals that were received from highly qualified research teams at prestigious cancer centers spanning the globe. Following an extensive peer review process consisting of an external advisory board, PCF selected the top research proposals for funding. These projects represent a range of focus and expertise and will address the most challenging problems in basic or translational research in prostate cancer. These Challenge Awards include 7 Movember-PCF Challenge Awards and 1 Judge A. David Mazzone-PCF Challenge Award. The Challenge Award Class of 2013 represents a $8.5 Million investment in advanced prostate cancer research.

View the recipients here 


CHALLENGE AWARDS—CLASS OF 2012

PCF selected the 9 2012 Challenge Awards out of 96 proposals from highly-qualified research teams at 70 prestigious cancer centers spanning 10 countries across the globe. Following an extensive peer review consisting of an external advisory board, PCF selected the top research proposals for funding. These projects represent a range of focus and expertise and will address the most challenging problems in basic or translational research in prostate cancer. These Challenge Awards include 2 Judge A. David Mazzone-PCF Challenge Awards and 3 Movember-PCF Challenge Awards. The Challenge Award Class of 2012 represents a $9 Million investment in advanced prostate cancer research..  

View the recipients here 


CHALLENGE AWARDS—CLASS OF 2011

PCF vetted the 10 2011 Challenge Awards from a field of 59 research proposals from highly-qualified research teams at prestigious cancer centers around the globe. Following an extensive peer review, consisting of an external advisory board, PCF selected the top research proposals for funding. These projects represent a range of focus and expertise and will address the most challenging problems in basic or translational research in prostate cancer. The 10 Challenge Awards include two Judge A. David Mazzone-PCF Challenge Awards.  

View the recipients here 


CHALLENGE AWARDS—CLASS OF 2008

Translational research experts rigorously reviewed a wealth of proposals so PCF could provide Challenge Award funds to the top 9 teams in less than 100 days. 

View the recipients here 


CREATIVITY AWARDS—CLASS OF 2011

A rigorous peer review process vetted the 14 selected projects from a field of more than 200 applications representing leading institutions in 11 countries. Historically, 70 percent of such PCF awards have gone on to attract additional multi-year funding from PCF and other sources..

These two-year awards are designed to support new ideas that may lead to the development of better diagnostics, new treatments and even cures for prostate cancer. The type of research ideas encouraged by PCF’s Creativity Awards are typically not funded by any existing government or other private sources.

View the recipients here


CREATIVITY AWARDS—CLASS OF 2010

The peer review process vetted the 12 selected projects from a field of more than 157 applications representing 92 institutions in 11 countries.

View the recipients here


CREATIVITY AWARDS—CLASS OF 2009

Following a rigorous peer review process, PCF selected 10 Creativity Award recipients from more than 300 applications representing 105 institutions in 11 countries.

The projects represent a range of research areas, from biomarkers for earlier and more precise detection and treatment to the development of new, nano-enabled therapeutics for metastases.

View the recipients here

Print | Bookmark and Share

manhood for good

Progress Reports

prostate cancer guides and books

prostate cancer clinical trials

patient support

athletes for a cure

facebook Google+ twitter linkedin